Bristol-Myers Squibb

Bristol-Myers Squibb's success in Tampa was a major draw for Johnson & Johnson
Bizjournals.com
Thu, 08/27/15 - 05:26 pm
Bristol-Myers Squibb
Tampa
JNJ
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Why Gilead Sciences, Inc. Can Easily Take Over Bristol-Myers Squibb Co
Bidness, ETC
Thu, 08/27/15 - 09:52 am
Gilead Sciences
Bristol-Myers Squibb
M&A
Bristol-Myers JV licenses immuno-oncology assets from Yale
Fierce Pharma
Thu, 08/27/15 - 09:45 am
immuno-oncology
Bristol-Myers Squibb
Yale
Allied Minds
Bristol-Myers, Sanofi prevail in Plavix false claims case
BioPharma Dive
Wed, 08/26/15 - 10:59 am
Plavix
whistleblower lawsuits
False Claims Act
Sanofi
Bristol-Myers Squibb
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
Wed, 08/19/15 - 09:17 pm
GSK
ViiV Healthcare
Gilead
Pfizer
Bristol-Myers Squibb
HIV
Big Pharma still a big deal for NJ economy, despite cost cuts
Fierce Pharma
Wed, 08/19/15 - 12:21 pm
Big Pharma
New Jersey
JNJ
Merck
Novartis
Bristol-Myers Squibb
Sanofi
Bayer
Roche
4 Top Pharma Stocks That Should Outperform Out To 2016
24/7 Wall St
Tue, 08/18/15 - 09:44 am
AbbVie
Bristol-Myers Squibb
Eli Lilly
Merck
Why the FDA Extended Review Date on Key Melanoma Drug Opdivo
24/7 Wall St
Thu, 08/13/15 - 08:43 am
melanoma
FDA
Opdivo
Bristol-Myers Squibb
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Merck's Keytruda gains market share in Q2
Medical Marketing and Media
Wed, 07/29/15 - 10:33 am
Merck
Keytruda
anti-PD-1 immunotherapy
Opdivo
Bristol-Myers Squibb
Are These 2 Big Pharmas Really Buyout Candidates?
Motley Fool
Tue, 07/28/15 - 10:05 am
M&A
Bristol-Myers Squibb
AstraZeneca
Pfizer
Gilead Sciences
Bristol-Myers snags a hep C approval to piggyback on Gilead's blockbuster
Fierce Biotech
Mon, 07/27/15 - 01:28 pm
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
AbbVie
Bristol-Myers Squibb
hepatitis C
FDA
Technivie
Daklinza
Bristol-Myers Squibb Gets a Mixed Message From Investors
Motley Fool
Thu, 07/23/15 - 11:18 pm
Bristol-Myers Squibb
investors
earnings
Bristol-Myers Squibb reports 2nd-quarter loss of $130 million
Yahoo/AP
Thu, 07/23/15 - 09:11 am
earnings
Bristol-Myers Squibb
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer
Fierce Biotech
Mon, 07/20/15 - 09:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
6 Big-Cap Drugmakers Reporting Earnings Next Week
Investors.com
Sat, 07/18/15 - 11:00 am
earnings
Novartis
Bristol-Myers Squibb
Eli Lilly
Valeant Pharmaceuticals
AbbVie
Biogen

Pages